BOTHELL, Wash., Sept. 3, 2014 /PRNewswire/ -- Alpinion Medical Systems, a leader in the development of diagnostic ultrasound, transducers, and HIFU, unveiled its innovative E-CUBE 12R clinical research platform at the 2014 IEEE International Ultrasonics Symposium (Booth #413) in Chicago from September 3-6.
Featuring advanced software beamforming technology and a frame rate of over nine thousand frames per second, the E-CUBE 12R can acquire high-resolution raw (pre-beamformed) RF data in real-time, flexible Python sequence programming, capability to generate arbitrary waveform, wide range of transmit/receive control parameters, offering users endless potential for research and clinical applications.
"With our E-CUBE 12R platform researchers have the flexibility and software customization they demand, without having to build their own research platform from the ground up," says Seokbin Ko, President and CEO of Alpinion Medical Systems. "We believe this research platform will support users, opening up new research opportunities and creating more valuable translational studies, bridging the gap from research to the commercialization of clinical applications. We are also pursuing early access to academic institutions for licensing new clinical applications to address unmet medical needs"
Alpinion's latest research platform with clinical scanning capabilities (FDA 510K in progress) features:
- Open software based platform allows researchers to manipulate the sequence program
- Innovative beamforming technology provides RF channel data access in real-time, without the need for additional hardware
- Freely process and reconstruct the pre-beamformed and post-beamformed non-decimated pixel RF data in the system environment
- Highly customizable sequence programmability allows researchers to manipulate all parameters, including transmit level, receive level, transducer settings and more
- Arbitrary transmission waveform generation
- Multi-live mode allows two different modes to be displayed side-by-side in real-time
- Acoustic Radiation Force Impulse (ARFI) controls
About Alpinion Medical Systems
Alpinion Medical Systems is a leader in the development and production of diagnostic ultrasound, therapeutic HIFU (high-intensity focused ultrasound) and advanced transducer technology. Winner of the reddot Design Award and iF Design Award for excellence in product innovation, its E-CUBE portfolio of diagnostic ultrasound platforms range from premium to portable systems. For more information please visit AlpinionUSA.com.
Related medicine technology :1
|SOURCE Alpinion Medical Systems|
Copyright©2014 PR Newswire.
All rights reserved
. The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies2
. PCMA: Medicare Part D 2015 Premiums Remain Flat3
. New Study: Medicare Preferred Pharmacy Network Plans Offer Lower Average Premiums, Same Quality as Non-Preferred Network Plans4
. Contrasting Reimbursement Environments Result in Different Prescribing Patterns for Premium-Priced Therapies in China and South Korea5
. Philips launches new EPIQ premium ultrasound system with first-of-its-kind nSIGHT technology and Anatomical Intelligence, to address complicated imaging needs of an aging global population6
. Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential7
. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 20158
. $4 Co-pay on Kroger Premium Blood Glucose Test Strips9
. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities10
. Edison Pharmaceuticals Announces Phase 2 Positive Clinical Results for EPI-743 in Rett Syndrome11
. FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply